Autoimmune Life Blog

We recently kicked off a potentially game-changing partnership with the new Allen Institute for Immunology. Fueled by a $125 million gift from the late Paul G. Allen, this partnership aims to learn more about how the immune system works from health to disease.

When some people are diagnosed with type 1 diabetes (T1D), the disease progresses so quickly that their pancreas stops making insulin within a year.  For others, the process is slower and this can make their T1D easier to manage.  But what if we could identify these fast progressors early, and ma

BRI is inviting Seattle-area adults to participate in the Sound Life Project, a groundbreaking research study to build a baseline of knowledge over time about the human immune system to better understand disease.

Matt Dufort, PhD, fights diabetes one data point at a time. Matt is a bioinformatician at Benaroya Research Institute at Virginia Mason (BRI), where he’s been using his data wrangling and analysis skills to find ways to prevent pancreatic damage in people living with type 1 diabetes (T1D).

What is the difference between an individual whose pancreas will continue producing insulin for 50 years, versus someone whose body may suddenly stop generating it within the next 18 months? That is the question Cate Speake, PhD, spends her days trying to answer.

Managing your autoimmune disease may require quick and easy access to a bathroom, checking your blood sugar in public, finding a step-free route into a store, or knowing that safe foods will be on the menu.

Megan and Madeline Coder are twins who do everything together — like ballet and even raising sheep in their hometown, Battle Ground, Washington. But in the fall of 2014, when Megan was nine, she learned she had something that Madeline didn’t: type 1 diabetes (T1D).

My son Peter was diagnosed with type 1 diabetes in 2013, just a few days before his third birthday. The years since have been a trial-by-fire learning experience.

BRI’s Matt Dufort, PhD, and Peter Linsley, PhD, led two new studies that could help doctors predict how quickly type 1 diabetes (T1D) will progress in some people, and match them with treatments that could slow it down. Dr.

In the late 1970s, Virginia Mason researchers had a groundbreaking idea: Use a portable pump to deliver insulin in patients with type 1 diabetes (T1D).